Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule
- PMID: 15939879
- PMCID: PMC1150828
- DOI: 10.1073/pnas.0501863102
Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule
Abstract
Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of the zoonotic disease Q fever. Acute human Q fever is characterized by flu-like symptoms that, in some cases, can result in a persistent infection that may reactivate months or years after initial exposure. Mechanisms by which this obligate parasite evades clearance by the host immune response during persistent infection are unknown. Here, we characterized the interaction of C. burnetii with dendritic cells (DC), critical components of both innate and adaptive immunity. Human DC were infected with two isogenic C. burnetii strains that differ in LPS length. Infection by the Nine Mile phase I (NMI) strain, which is fully virulent and produces full-length LPS, did not result in DC maturation. In contrast, infection by the avirulent Nine Mile phase II strain, producing a severely truncated LPS, resulted in toll-like receptor 4-independent DC maturation and approximately 10-fold more IL-12 and TNF production. NMI did not actively inhibit DC maturation as NMI-infected DC subsequently matured if treated with Escherichia coli LPS or Nine Mile phase II. Furthermore, removal of LPS from NMI dramatically increased its ability to stimulate DC. We propose a model whereby LPS of virulent C. burnetii masks toll-like receptor ligands from innate immune recognition by DC, thereby allowing replication without significant maturation or inflammatory cytokine production. This immune evasion strategy may allow C. burnetii to persist in an immunocompetent host.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010006.gif)
![Fig. 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1150828/bin/zpq0250586010007.gif)
Similar articles
-
Lack of dendritic cell maturation following infection by Coxiella burnetii synthesizing different lipopolysaccharide chemotypes.Ann N Y Acad Sci. 2005 Dec;1063:154-60. doi: 10.1196/annals.1355.024. Ann N Y Acad Sci. 2005. PMID: 16481507
-
Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.J Immunol. 2004 Mar 15;172(6):3695-703. doi: 10.4049/jimmunol.172.6.3695. J Immunol. 2004. PMID: 15004173
-
Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.J Biol Chem. 2004 Dec 24;279(52):54405-15. doi: 10.1074/jbc.M410340200. Epub 2004 Oct 13. J Biol Chem. 2004. PMID: 15485838
-
Lipopolysaccharide of Coxiella burnetii.Adv Exp Med Biol. 2012;984:65-90. doi: 10.1007/978-94-007-4315-1_4. Adv Exp Med Biol. 2012. PMID: 22711627 Review.
-
Coxiella burnetii Lipopolysaccharide: What Do We Know?Int J Mol Sci. 2017 Nov 23;18(12):2509. doi: 10.3390/ijms18122509. Int J Mol Sci. 2017. PMID: 29168790 Free PMC article. Review.
Cited by
-
Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria.Front Cell Infect Microbiol. 2024 Mar 19;14:1282183. doi: 10.3389/fcimb.2024.1282183. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38567021 Free PMC article. Review.
-
Drosophila melanogaster Sting mediates Coxiella burnetii infection by reducing accumulation of reactive oxygen species.Infect Immun. 2024 Mar 12;92(3):e0056022. doi: 10.1128/iai.00560-22. Epub 2024 Feb 16. Infect Immun. 2024. PMID: 38363133 Free PMC article.
-
Q fever immunology: the quest for a safe and effective vaccine.NPJ Vaccines. 2023 Sep 7;8(1):133. doi: 10.1038/s41541-023-00727-6. NPJ Vaccines. 2023. PMID: 37679410 Free PMC article. Review.
-
A simple method for enrichment of phase I Coxiella burnetii.J Microbiol Methods. 2023 Aug;211:106787. doi: 10.1016/j.mimet.2023.106787. Epub 2023 Jul 14. J Microbiol Methods. 2023. PMID: 37453478 Free PMC article.
-
Identification of Type 4B Secretion System Substrates That Are Conserved among Coxiella burnetii Genomes and Promote Intracellular Growth.Microbiol Spectr. 2023 Jun 15;11(3):e0069623. doi: 10.1128/spectrum.00696-23. Epub 2023 May 18. Microbiol Spectr. 2023. PMID: 37199620 Free PMC article.
References
-
- Toman, R. & Skultety, L. (1996) Carbohydr. Res. 283, 175-185. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources